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Hearing loss is a prevalent human sensory defect. There are many people in the world who suffer from hearing impairment. According to the Macedonian Association of the Deaf and Hard of Hearing, there are 6000 deaf people in the Republic of Macedonia. The incidence of congenital hearing impairment is at least 1 child in every 1000 born, and an additional 1 child in 1000 progressively develops deafness (1, 2) .
Several environmental and genetic factors are causes of hearing loss. At least 50% of congenital hearing impairment has a genetic origin (3) . Late onset of hearing loss can also be caused by genetic defects. Approximately 70% of genetic cases are non-syndromic, where deafness is the only clinical manifestation. Non-syndromic hearing impairment is further categorized by the mode of inheritance. Autosomal recessive inheritance is found in 80% of cases, while approximately 20% are inherited in an autosomal dominant, X-linked (2% to 5%), or mitochondrial (1%) mode. The genetic basis of hearing loss is complex. It has been shown that more than 100 loci are involved in hearing loss (4) . Despite enormous genetic heterogeneity, mutation in the Deafness Autosomal Recessive 1-B (DFNB1) locus containing the Gap Junction Protein Beta 2 (GBJ2) gene (13q12.11) is the predominant cause of autosomal recessive non-syndromic hearing loss. DFBN1 is generally characterized by prelingual deafness. The GBJ2 gene encodes for connexin 26 (Cx26), which is a gap junction protein responsible for potassium transport and ion homeostasis. Several recurrent mutations have been found in GBJ2 (35delG, 167delT, and 235delC), with specific prevalence in different ethnic groups (5) (6) (7) (8) . Molecular testing for GBJ2 has become the standard of evaluation of patients with non-syndromic Background: Cochlear implants (CI) for the rehabilitation of patients with profound or total bilateral sensorineural hypoacusis represent the initial use of electrical fields to provide audibility in cases where the use of sound amplifiers does not provide satisfactory results. Aims: To compare speech perception performance after cochlear implantation in children with connexin 26-associated deafness with that of a control group of children with deafness of unknown etiology. Study Design: Retrospective comparative study. Methods: During the period from 2006 to , cochlear implantation was performed on 26 children. Eighteen of these children had undergone genetic tests for mutation of the Gap Junction Protein Beta 2 (GJB2) gene. Bi-allelic GJB2 mutations were confirmed in 7 out of 18 examined children. In order to confirm whether genetic factors have influence on speech perception after cochlear implantation, we compared the post-implantation speech performance of seven children with mutations of the GBJ2 (connexin 26) gene with seven other children who had the wild type version of this particular gene.
The latter were carefully matched according to the age at cochlear implantation. Speech perception performance was measured before cochlear implantation, and one and two years after implantation. All the patients were arranged in line with the appropriate speech perception category (SPC). Non-parametric tests, Friedman ANOVA and Mann-Whitney's U test were used for statistical analysis. Results: Both groups showed similar improvements in speech perception scores after cochlear implantation. Statistical analysis did not confirm significant differences between the groups 12 and 24 months after cochlear implantation.
Conclusion:
The results obtained in this study showed an absence of apparent distinctions in the scores of speech perception between the two examined groups and therefore might have significant implicaimpairment of unknown etiologies due to the high incidence of GBJ2 mutations. Studies on mutations in GJB2 in 120 persons with prelingual non-syndromic deafness in the Republic of Macedonia determined a prevalence of 25.8%, with 35delG as the most frequent variation found in 68.2% of mutated chromosomes, followed by W24X (18.2%), V371(9.1%), and R127H (4.5%) (9, 10).
One rehabilitation option for patients with severe to profound hearing loss is cochlear implantation. However, the performance of cochlear implants is very inconsistent and depends on many factors, such as the age of implantation, amount of residual hearing, and mode of communication. These factors can contribute to speech perception abilities but explain less than 50% of the variance in the results (11) (12) (13) . The general opinion is that speech perception performance after cochlear implantation might be poorer due to primary reasons including neural or central damage of the auditory system, rather than causes primarily affecting the hair cells (e.g. hereditary non-syndromic deafness) such as connexin 26 mutation deafness (12, 13) .
The aim of this study was to compare the speech perception performance after cochlear implantation in children with connexin 26-associated deafness with other children carrying the wild type connexin 26 gene.
MATERIAL AND METHODS

Subjects and selection criteria
In the period from 2006-2012 cochlear implantation was undertaken in 30 children at the University Ear, Nose and Throat Clinic in Skopje, Republic of Macedonia. Each of them had information consent. This study was approved by Ethical Comitee of the Medical Faculty in Skopje.
Audiological evaluation
All patients underwent audiometric examination using ageappropriate methods: pure tone audiometry, auditory brain-stem responses (ABR), otoacoustic emissions and tympanometry (Audiometar CA-540, Octavus BERA, ILO 88 Hortman Otoacoustic Emissions, Tympanometar 87). The examinations were carried out at the Audiology Department of the University ENT Clinic, Skopje, R. Macedonia. All patients were diagnosed with profound hearing loss at 1.5 to 2.6 years of age and were implanted at 2.9 to 5.6 years of age.
All of the patients underwent a battery of cognitive, neurological and psychological tests consisted of: body mass and primitive reflexes assessment, motility assessment according to the corrected gestational age, and developmental assessment according BagleGriffiths developmental scales for 0-2 years and 2-7 years. No evidence of additional impairments or handicaps was found in either group. High-resolution CT imaging showed that there were no inner ear anomalies.
Molecular genetic analysis
Eighteen patients underwent genetic analysis at the Research Center of Genetic Engineering and Biotechnology "Georgi D. Efremov", Skopje, R. Macedonia. Written information consent was obtained from all participants or parents in the case of minors. DNA from 18 patients was extracted according to the standard phenol/ chloroform extraction ethanol precipitation procedure. The coding region of the gene was amplified in two separate PCR assays and subsequently sequenced using the Big Dye v 1.1 sequencing kit and electrophoresis on an ABI 3130 apparatus (Applied Bio systems). Of these, seven patients had bi-allelic GJB2 mutations that were the underlying cause of hearing impairment. Two patients had mono-allelic GJB2 mutations and the remaining nine patients had wild type alleles. Patients with mono-allelic GJB2 mutations were excluded from this investigation since the genetic origin of the deafness could not be explicitly confirmed.
Based on the genetic results, patients in this study were classified into two groups: seven patients with DFNB1 deafness (when biallelic mutations for GJB2 were detected ) and seven patients of the total of nine that served as a control group with no DFNB1 deafness (when no mutations were identified). The control patients were carefully matched according to the age of receipt of the cochlear implant.
Speech perception evaluation
Speech perception tests were performed by speech pathologists at the Hearing and Speech Rehabilitation Center, Skopje, R. Macedonia. The IT-MAIS test for preverbal children and tests for early speech perception were used. Perception categories were assigned to results appropriate to the speech perception category (SPC), as described by Moog and Geers (14) . The scale with six levels includes categories where 0 means there is no detection, 1 stands for detection only, 2 for pattern perception, 3 for inconsistent closed-set word recognition and multiple spectral differences, 4 for consistent closed-set word recognition of vowels, 5 for consistent closed-set word recognition of consonants and 6 for open-set word recognition.
All tests were performed at the 70 dB sound pressure level via live voice, at a distance of one meter between the speaker/speech pathologist and the listener/examinee. Speech perception ability was measured before cochlear implantation, and 12 and 24 months after surgery. Statistical analysis was performed by the non-parametric Friedman ANOVA test and Mann-Whitney's U test.
RESULTS
The follow-up tests showed no differences between the two groups in terms of the mean age of implantation and duration of cochlear implant use. Communication mode and pure tone average before implantation (dB) were found to be similar between the two groups. Table 1 gives the background data of two groups (DFNB1 group and control -non DFNB1 group).
Eighteen cochlear implanted patients underwent genetic examination. As shown in Table 1 , seven patients who had bi-allelic DFNB1 mutations and seven patients who had wild type alleles of this particular gene were analyzed.
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Statistical analysis using non-parametric Friedman ANO-VA test showed significantly greater differences in speech perception scores during the analyzed period before implantation, and 12 and 24 months after cochlear implantation for the DFNB1group (p=0.0009) and for the non-DFNB1 group (p=0.001). The results show that children who obtained cochlear implants demonstrated a rapid improvement in hearing abilities in the first year of device implantation as well as after the second year.
The mean SPC for DFNB1 patients was 3.29±0.3 and 3.25±0.33 for non-DFNB1 patients 12 months after cochlear implantation. After 24 months, the mean SPC for DFNB1 and non-DFNB1 patients was 4.86±0.38 and 4.7±0.47, respectively. Statistical analysis using the non-parametric Mann-Whitney's U test did not confirm substantial variations between the groups 12 months after cochlear implantation (p=0.56) and 24 months after cochlear implantation (p=0.37). These results are illustrated in Figure 1 .
DISCUSSION
According to some authors, many different factors influence the evaluation of speech perception outcomes in cochlear implanted children . A recent systematic pediatric cochlear implantation review demonstrated only three factors that sustained critical analysis. These were: late age of implantation, inner ear malformations and meningitis. In this review, connexin 26 (GJB2) mutations had a negligible impact (14) .
Other authors have considered that the existence of biallelic GJB2 mutations does not rule out non-hearing related disorders that can affect speech, language and learning. They concluded that other conditions could directly affect pre-implant evaluation and post-implant function, and that all children should have a comprehensive assessment of development and behavior, regardless of the etiology of hearing loss (15) .
The aim of this study was to compare speech perception outcomes after cochlear implantation in children with GJB2/ DFNB1 associated deafness without other comorbid conditions to children with deafness of unknown etiology and to determine the impact of this mutation on speech perception outcomes. The results show that cochlear implantation is effective in the development of speech perception after cochlear implantation in GJB2-related deafness to a similar extent as in deafness due to unknown etiology. These findings are in agreement with findings obtained by other authors (4, 13, (15) (16) (17) (18) (19) (20) (21) (22) . A recent long term follow-up of cochlear implantation in children with GBJ2-related deafness in Japan showed similar developments in speech performance in comparison with hearing loss due to other etiologies (23) .
Some studies have shown that children with the connexin 26 mutation had better speech perception outcomes after cochlear implantation and greater benefits in language expression tests than children with deafness of unknown etiology (24) (25) (26) . A recent study of Portuguese children with cochlear implants showed that DFNB1 status is significantly associated to higher oral performance scores, i.e. 6% better than individuals without DFNB1-associated deafness (27) . These different findings might be a result of the use of different tests for evaluating speech perception performance, insufficient follow-up after cochlear implantation or different criteria for inclusion or exclusion of children during the evaluation of speech perception.
We consider that future analyses are necessary, including a large number of implanted patients in whom other confounding factors are precluded. Our findings did not confirm significant differences regarding speech perception performance after cochlear implantation in children with connexin 26-associated deafness with that of a control group of children with deafness of unknown etiology. We consider that the information from this study will have great influence on the selection of predictive indicators of speech perception outcomes following cochlear implantation.
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